Pharsight

Drugs that contain Estradiol; Progesterone

1. Bijuva patents expiration

BIJUVA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10675288 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US10052386 THERAPEUTICSMD INC Progesterone formulations
Nov, 2032

(8 years from now)

US10639375 THERAPEUTICSMD INC Progesterone formulations
Nov, 2032

(8 years from now)

US8987237 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US8993548 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US11110099 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US11103516 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US10206932 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US8846649 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US8846648 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US9114146 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US9114145 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US9301920 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US11033626 THERAPEUTICSMD INC Progesterone formulations having a desirable pk profile
Nov, 2032

(8 years from now)

US9006222 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US10806740 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US11103513 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US8933059 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US11166963 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US8633178 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US8993549 THERAPEUTICSMD INC Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

Market Authorisation Date: 28 October, 2018

Treatment: Treatment of menopause symptoms, including vasomotor symptoms

Dosage: CAPSULE;ORAL

How can I launch a generic of BIJUVA before it's drug patent expiration?
More Information on Dosage

BIJUVA family patents

Family Patents

2. Bijuva patents expiration

BIJUVA's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11865179 MAYNE PHARMA Progesterone formulations having a desirable PK profile
Nov, 2032

(8 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11529360 MAYNE PHARMA Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

US11793819 MAYNE PHARMA Natural combination hormone replacement formulations and therapies
Nov, 2032

(8 years from now)

Market Authorisation Date: 28 October, 2018

Treatment: Treatment of menopause symptoms, including vasomotor symptoms

Dosage: CAPSULE;ORAL

How can I launch a generic of BIJUVA before it's drug patent expiration?
More Information on Dosage

BIJUVA family patents

Family Patents